PD-L1 Inhibitors Archives - Clinical FAQ Your go-to source for addressing common clinical medicine questions, empowering you to make informed decisions and stay up-to-date on the latest medical breakthroughs Sat, 15 Apr 2023 14:24:37 +0000 en-US hourly 1 https://clinicalfaq.com/wp-content/uploads/2023/04/Clinical-FAQ-Favicon-512x512-1-150x150.png PD-L1 Inhibitors Archives - Clinical FAQ 32 32 Immune Checkpoint Inhibitors, PD-1, and PD-L1 Explained https://clinicalfaq.com/biotechnology/immune-checkpoint-inhibitors-pd-1-and-pd-l1-explained/ https://clinicalfaq.com/biotechnology/immune-checkpoint-inhibitors-pd-1-and-pd-l1-explained/#respond Sun, 09 Apr 2023 17:07:27 +0000 https://clinicalfaq.com/?p=184 Both PD-L1 and PD-1 inhibitors work by disrupting the interaction between PD-L1 and PD-1, effectively "releasing the brakes" on the immune system and allowing T cells to recognize and attack cancer cells more effectively. While they target different proteins, their overall goal is the same: to enhance the immune system's ability to fight cancer.

The post Immune Checkpoint Inhibitors, PD-1, and PD-L1 Explained appeared first on Clinical FAQ.

]]> https://clinicalfaq.com/biotechnology/immune-checkpoint-inhibitors-pd-1-and-pd-l1-explained/feed/ 0